Immune System News and Research

RSS

Research reveals a potential 'chink in the armor' of SARS-CoV-2

The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.

6 Apr 2020

Autoimmunity-associated heart dilation linked with heart-failure risk in type 1 diabetes

People with type 1 diabetes, particularly those with poor glycemic control, are at markedly increased risk for cardiovascular disease than the general population.

6 Apr 2020

Shorter-course radiotherapy will benefit bowel cancer patients during COVID-19

An international panel of cancer experts has recommended a one-week course of radiotherapy and delaying surgery as the best way to treat patients with bowel cancer during the COVID-19 pandemic.

6 Apr 2020

UC San Diego Health expands COVID-19 testing capacity

From the beginning, the ability of front line clinicians to test patients for COVID-19 -- to determine whether a person is infected with the disease-causing novel coronavirus, SARS-CoV-2 -- has been part and parcel of the pandemic.

6 Apr 2020

Immunotherapy prior to surgery is effective in colon cancer

Patients with colon cancer, but no distant metastases, can benefit from immunotherapy while waiting for surgery.

6 Apr 2020

‘Staying away from grandma’ isn’t an option in multigenerational homes

The Walker family never thought having an age range of 3 to 96 under the same roof would be risky.

6 Apr 2020

Horizon Discovery expands cell-based CRISPR screening services

Horizon Discovery Group plc, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells.

From Revvity 6 Apr 2020

First genome sequences of SARS-CoV-2 viruses in Austria openly available

The first 21 SARS-CoV-2 genomes in Austria have now been completed and published within the scope of the “Mutational Dynamics of SARS-CoV-2” project recently launched by CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, in close collaboration with the Medical University of Vienna.

3 Apr 2020

St George's, University of London focuses entire research on tackling coronavirus

St George's, University of London, the UK's specialist health university, is focusing all its ongoing research on tackling coronavirus.

3 Apr 2020

New molecular mechanism that regulates the sentinel cells of the immune system

A study suggests that it may be possible to regulate macrophages with drugs that modulate the nuclear receptor RXR.

3 Apr 2020

Therapeutic cooling could mitigate damage to concussed cells

In the future, treating a concussion could be as simple as cooling the brain.

2 Apr 2020

Study shows how Toxoplasma infection causes seizures, psychiatric illness for some

Think about traffic flow in a city - there are stop signs, one-way streets, and traffic lights to organize movement across a widespread network. Now, imagine what would happen if you removed some of the traffic signals.

2 Apr 2020

Scientists find important clues to vaccine in SARS-CoV-2 genome

A new research paper published by scientists at the University of Bristol who sequenced the genome of the SARS-CoV-2 virus, which is causing the worldwide COVID-19 illness, reveals some significant findings that could help researchers working on rolling out vaccines to stop the relentless march of the virus. The study was published online on the preprint site bioRxiv in April 2020.

2 Apr 2020

Study investigates if the body's immune response to infections changes with seasons

Ground breaking new research is underway at the University of Surrey in collaboration with Columbia University to investigate if the body's immune response to infectious diseases and viruses, such as COVID-19, is altered by different seasons.

2 Apr 2020

Putting an end to the pandemic

From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations of writers and vexed conspiracy theorists.

1 Apr 2020

Immunotherapy may benefit mCRPC patients with specific markers of immune activation

Although metastatic castration-resistant prostate cancer typically has limited response to immunotherapy, a subset of patients with pretreatment evidence of active T-cell responses in their tumors experienced prolonged survival following treatment with ipilimumab in a Phase II trial at The University of Texas MD Anderson Cancer Center.

1 Apr 2020

New collaboration may lead to future clinical trials to test treatment for leukemia

In a new pre-clinical study published this week in the journal Leukemia, the research team of Children's Hospital Los Angeles investigator Hisham Abdel-Azim, MD, MS, worked with colleagues to engineer T-cells to identify and target multiple sites on acute lymphoblastic leukemia cells instead of just one. The early collaboration points the way to future clinical trials to test the therapy.

1 Apr 2020

Stem cells used to combat COVID-19 pneumonia

The novel coronavirus first emerged in December 2019, and since then, it rippled across 180 countries, affecting hundreds of thousands of people. Amid the coronavirus disease (COVID-19) pandemic, many people are looking for answers. Scientists are racing to find a treatment that can help save lives. Now, a team of scientists has suggested that stem cell therapy can help fight the deadly infection.

1 Apr 2020

ERC awards grants to 158 European scientists to identify effective immunotherapy strategies for cancer

The European Research Council (ERC) has announced it will support Professor Thomas Blankenstein to the tune of €2.5 million over five years. This year the ERC is awarding Advanced Grants to a total of 158 scientists across Europe.

1 Apr 2020

Researchers say that NSAIDs, JAK inhibitors and TNF blockers are safe to use in COVID-19

Amid the coronavirus disease (COVID-19) pandemic, many theories have emerged about the disease and the treatments that can in supportive care. A recent theory emerged that suggests non-steroidal anti-inflammatory drugs (NSAIDs) might exacerbate the symptoms of the novel coronavirus. Now, a new study shows that there is no evidence for or against the use of NSAIDS, particularly ibuprofen, for patients with COVID-19.

1 Apr 2020

Immune System News and Research

Research reveals a potential 'chink in the armor' of SARS-CoV-2

Autoimmunity-associated heart dilation linked with heart-failure risk in type 1 diabetes

Shorter-course radiotherapy will benefit bowel cancer patients during COVID-19

UC San Diego Health expands COVID-19 testing capacity

Immunotherapy prior to surgery is effective in colon cancer

‘Staying away from grandma’ isn’t an option in multigenerational homes

Horizon Discovery expands cell-based CRISPR screening services

First genome sequences of SARS-CoV-2 viruses in Austria openly available

St George's, University of London focuses entire research on tackling coronavirus

New molecular mechanism that regulates the sentinel cells of the immune system

Therapeutic cooling could mitigate damage to concussed cells

Study shows how Toxoplasma infection causes seizures, psychiatric illness for some

Scientists find important clues to vaccine in SARS-CoV-2 genome

Study investigates if the body's immune response to infections changes with seasons

Putting an end to the pandemic

Immunotherapy may benefit mCRPC patients with specific markers of immune activation

New collaboration may lead to future clinical trials to test treatment for leukemia

Stem cells used to combat COVID-19 pneumonia

ERC awards grants to 158 European scientists to identify effective immunotherapy strategies for cancer

Researchers say that NSAIDs, JAK inhibitors and TNF blockers are safe to use in COVID-19

Immunology eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News